TMTP1-ICG Mapping in Colposcopy-directed Biopsy

• Status: Active, not recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Investigators aimed to determine the validity of the novel tumor targeted fluorescent TMTP1-ICG to increased accuracy of colposcopy-directed biopsy.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Huazhong University of Science and Technology

Criteria

Inclusion Criteria:

• Suspicious of cervical disease required a colposcopy-directed biopsy.

• Subjects must sign an informed consent indicating awareness of the investigational nature of this study.

Exclusion Criteria:

• Breast-feeding or pregnant.

• Ongoing participation in another clinical trial with an investigational drug with 3 months.

• Own allergy towards ICG and/or alcohol.

• Diagnosis of bacterial vaginosis, fungal vaginitis, sexually transmitted diseases.

• Patients with cardiac dysfunction or hepatic insufficiency or renal insufficiency.